Stock Track | Option Care Health Plummets 9.80% in Pre-Market as 2025 Guidance Fails to Impress Investors

Stock Track10-30

Option Care Health Inc (OPCH) saw its stock price plummet by 9.80% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.

For the third quarter ended September 30, 2025, Option Care Health reported strong financial results. The company's revenue reached $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. Adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42, while adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.

However, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with current estimates. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the significant sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1178443186?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178443186","market":"us","top_or_hot":-1,"title":"Stock Track | Option Care Health Plummets 9.80% in Pre-Market as 2025 Guidance Fails to Impress Investors","media":"Stock Track","content":"<p>Option Care Health Inc (OPCH) saw its stock price plummet by 9.80% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.</p>\n\n<p>For the third quarter ended September 30, 2025, Option Care Health reported strong financial results. The company's revenue reached $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. Adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42, while adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.</p>\n\n<p>However, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with current estimates. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the significant sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Option Care Health Plummets 9.80% in Pre-Market as 2025 Guidance Fails to Impress Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Option Care Health Plummets 9.80% in Pre-Market as 2025 Guidance Fails to Impress Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-30 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Option Care Health Inc (OPCH) saw its stock price plummet by 9.80% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.</p>\n\n<p>For the third quarter ended September 30, 2025, Option Care Health reported strong financial results. The company's revenue reached $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. Adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42, while adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.</p>\n\n<p>However, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with current estimates. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the significant sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPCH","symbol_name":"Option Care Health Inc","start_time":0,"source_url":"","article_id":"1178443186","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178443186","pubTimestamp":1761831642,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Option Care Health Inc (OPCH) saw its stock price plummet by 9.80% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPCH":"Option Care Health Inc"},"translate_title":"个股赛道|Option Care Health盘前暴跌9.80%2025年指引未能打动投资者","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPCH":1},"content_text":"Option Care Health Inc (OPCH) saw its stock price plummet by 9.80% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.\nFor the third quarter ended September 30, 2025, Option Care Health reported strong financial results. The company's revenue reached $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. Adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42, while adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.\nHowever, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with current estimates. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the significant sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178443186","isCrawlerRequest":true}